Skip to main content
Funding Opportunities

PS-ON Funding Opportunities

Title Announcement Number Upcoming Application Receipt Date(s) Expiration Date Activity Code
Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) PAR-22-147 07/08/2022; 11/01/2022; 07/03/2022; 11/01/2023; 07/01/2024; 11/01/2024 11/02/2024 U01
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) PAR-22-099 Standard Dates 05/08/2025 R01
Notice of Special Interest (NOSI): Availability of Administrative Supplements to Harmonize / Map Existing Data to NCI Human Tumor Atlas Network Data Standards NOT-CA-22-013 N/A (applications can be submitted on a rolling basis)  07/31/2022 N/A
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) PAR-20-074 10/26/2021; 02/28/2022; 07/11/2022; 10/28/2022 10/29/2022 R01
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) RFA-CA-21-048 11/12/2021; 10/19/2022 10/20/2022 U54

Past PS-ON Funding Opportunities

Title Announcement Number Expiration Date Activity Code
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) PAR-19-113 01/08/2022 R01
Physical Sciences – Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional) PAR-19-101 10/01/2020 U01
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01) PAR-17-171 12/17/2018 R01
Physical Sciences – Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01) PAR-15-021 09/22/2017 U01
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01) PAR-16-105 01/27/2017 U01
Physical Sciences – Oncology Network (PS-ON): Physical Sciences-Oncology Centers (PS-OC) (U54) PAR-14-169 11/26/2015 U54
Physical Science-Oncology Centers (U54) RFA-CA-09-009 03/14/2009 U54
  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “PS-ON Funding Opportunities was originally published by the National Cancer Institute.”